StockData
Novartis AG logo

Novartis AG

NVSNYSEPharmaceutical PreparationsFiscal year ends December 31Also trades as NVSEF
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 20-F on Feb 4, 2026Score 7/30
$160.79−0.31 (-0.19%)

Close on Oct 30, 2026Market cap $306.81BP/E 22.5Yield –

Novartis Reported Net Sales Growth in USD by Quarter

Reported Net Sales Growth in USD (% YoY USD) (%)

QuarterlyAnnual

Novartis Reported Net Sales Growth in USD: 4.0% in Q3 2026, down 4.0 pts from a year earlier.

Latest, Q3 2026
4.0%
Period ended Sep 30, 2026
Change on a year earlier
-4.0 pts
8.0% in Q3 2025
History
26 quarters
Since Q2 2020
Sources
26
Documents cited below

Where the Q3 2026 figure comes from

“|| Total net sales to third parties | 14 522 | 13 909 | 4 | 4”

Source: Novartis Form 6-K (0001114448-26-000014) ↗

Reported in Form 6-K & Form 20-F.

Quarterly history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedReported Net Sales Growth in USD (% YoY USD) (%)Year on yearSource
Q3 2026Sep 30, 20264.0%-4.0 ptsNovartis Form 6-K (0001114448-26-000014) ↗
Q2 2026Jun 30, 20263.0%-9.0 ptsNovartis Form 6-K (0001114448-26-000012) ↗
Q1 2026Mar 31, 2026-1.0%-13.0 ptsNovartis Form 6-K (0001114448-26-000010) ↗
Q4 2025Dec 31, 20251.0%-14.0 ptsNovartis Form 6-K (0001114448-26-000007) ↗
Q3 2025Sep 30, 20258.0%-1.0 ptsNovartis Form 6-K (0001114448-25-000003) ↗
Q2 2025Jun 30, 202512.0%+3.0 ptsNovartis Form 6-K (0001370368-25-000012) ↗
Q1 2025Mar 31, 202512.0%+2.0 ptsNovartis Form 6-K (0001370368-25-000010) ↗
Q4 2024Dec 31, 202415.0%+7.0 ptsNovartis Form 6-K (0001370368-25-000007) ↗
Q3 2024Sep 30, 20249.0%-3.0 ptsNovartis Form 6-K (0001370368-24-000022) ↗
Q2 2024Jun 30, 20249.0%+4.0 ptsNovartis Form 6-K (0001370368-24-000019) ↗
Q1 2024Mar 31, 202410.0%+7.0 ptsNovartis Form 6-K (0001370368-24-000017) ↗
Q4 2023Dec 31, 20238.0%+10.0 ptsNovartis Form 6-K (0001370368-24-000007) ↗
Q3 2023Sep 30, 202312.0%+13.0 ptsNovartis Form 6-K (0001370368-23-000068) ↗
Q2 2023Jun 30, 20235.0%+5.0 ptsNovartis Form 6-K (0001370368-23-000059) ↗
Q1 2023Mar 31, 20233.0%+2.0 ptsNovartis Form 6-K (0001370368-23-000046) ↗
Q4 2022Dec 31, 2022-2.0%-8.0 ptsNovartis Form 6-K (0001370368-23-000008) ↗

Cite this data

StockData. (2026). Novartis Reported Net Sales Growth in USD (%), quarterly Q2 2020–Q3 2026 [Data set]. Compiled from Novartis SEC filings and investor materials. https://stockdatahq.com/stocks/nvs/kpis/net-sales-yoy-usd-pct

See every metric in the Novartis KPI table. Data updated Nov 2, 2026.